Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[In addition to previously described erbB2-regulating breast cancer Ets factors (PEA3, ESX/Elf-3), Elf-1 is now shown to be another endogenously expressed Ets candidate capable of binding to and upregulating the erbB2 promoter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP572525.RAC_3_ffotMKCUiCrPA_xHiL5xg1k0oixL_DUPe68k0mE130_assertion description "[In addition to previously described erbB2-regulating breast cancer Ets factors (PEA3, ESX/Elf-3), Elf-1 is now shown to be another endogenously expressed Ets candidate capable of binding to and upregulating the erbB2 promoter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP572525.RAC_3_ffotMKCUiCrPA_xHiL5xg1k0oixL_DUPe68k0mE130_provenance.
• assertion description "[In addition to previously described erbB2-regulating breast cancer Ets factors (PEA3, ESX/Elf-3), Elf-1 is now shown to be another endogenously expressed Ets candidate capable of binding to and upregulating the erbB2 promoter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In addition to previously described erbB2-regulating breast cancer Ets factors (PEA3, ESX/Elf-3), Elf-1 is now shown to be another endogenously expressed Ets candidate capable of binding to and upregulating the erbB2 promoter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In addition to previously described erbB2-regulating breast cancer Ets factors (PEA3, ESX/Elf-3), Elf-1 is now shown to be another endogenously expressed Ets candidate capable of binding to and upregulating the erbB2 promoter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In addition to previously described erbB2-regulating breast cancer Ets factors (PEA3, ESX/Elf-3), Elf-1 is now shown to be another endogenously expressed Ets candidate capable of binding to and upregulating the erbB2 promoter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In addition to previously described erbB2-regulating breast cancer Ets factors (PEA3, ESX/Elf-3), Elf-1 is now shown to be another endogenously expressed Ets candidate capable of binding to and upregulating the erbB2 promoter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In addition to previously described erbB2-regulating breast cancer Ets factors (PEA3, ESX/Elf-3), Elf-1 is now shown to be another endogenously expressed Ets candidate capable of binding to and upregulating the erbB2 promoter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In addition to previously described erbB2-regulating breast cancer Ets factors (PEA3, ESX/Elf-3), Elf-1 is now shown to be another endogenously expressed Ets candidate capable of binding to and upregulating the erbB2 promoter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In addition to previously described erbB2-regulating breast cancer Ets factors (PEA3, ESX/Elf-3), Elf-1 is now shown to be another endogenously expressed Ets candidate capable of binding to and upregulating the erbB2 promoter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP504672.RAJcEXgtZ7LY2Qyk3XMkAiKq5v9EBAeTTslc1Qp52Vr_E130_assertion description "[In addition to previously described erbB2-regulating breast cancer Ets factors (PEA3, ESX/Elf-3), Elf-1 is now shown to be another endogenously expressed Ets candidate capable of binding to and upregulating the erbB2 promoter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP504672.RAJcEXgtZ7LY2Qyk3XMkAiKq5v9EBAeTTslc1Qp52Vr_E130_provenance.
• assertion description "[In addition to previously described erbB2-regulating breast cancer Ets factors (PEA3, ESX/Elf-3), Elf-1 is now shown to be another endogenously expressed Ets candidate capable of binding to and upregulating the erbB2 promoter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In addition to previously described erbB2-regulating breast cancer Ets factors (PEA3, ESX/Elf-3), Elf-1 is now shown to be another endogenously expressed Ets candidate capable of binding to and upregulating the erbB2 promoter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP715653.RAOf_Ho8EClsQVsBerOvC07fQZA8dMcdyhj4rAAAaEbhk130_assertion description "[In addition to previously described erbB2-regulating breast cancer Ets factors (PEA3, ESX/Elf-3), Elf-1 is now shown to be another endogenously expressed Ets candidate capable of binding to and upregulating the erbB2 promoter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP715653.RAOf_Ho8EClsQVsBerOvC07fQZA8dMcdyhj4rAAAaEbhk130_provenance.
• NP307139.RARkp6KSa3TZgYEzmCHEIsf_0iavZYCTLDCrjLwnvxFIc130_assertion description "[In addition to previously described erbB2-regulating breast cancer Ets factors (PEA3, ESX/Elf-3), Elf-1 is now shown to be another endogenously expressed Ets candidate capable of binding to and upregulating the erbB2 promoter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP307139.RARkp6KSa3TZgYEzmCHEIsf_0iavZYCTLDCrjLwnvxFIc130_provenance.
• NP373172.RAh62JChFYp5Fh3W_m-LGeseL0ZWB11X5BDxloHCraMLU130_assertion description "[In addition to previously described erbB2-regulating breast cancer Ets factors (PEA3, ESX/Elf-3), Elf-1 is now shown to be another endogenously expressed Ets candidate capable of binding to and upregulating the erbB2 promoter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP373172.RAh62JChFYp5Fh3W_m-LGeseL0ZWB11X5BDxloHCraMLU130_provenance.
• NP307143.RAiUPzRdFA7nbE7t2c95cz4XfZwUe3BpnL5L1rWfUUvLk130_assertion description "[In addition to previously described erbB2-regulating breast cancer Ets factors (PEA3, ESX/Elf-3), Elf-1 is now shown to be another endogenously expressed Ets candidate capable of binding to and upregulating the erbB2 promoter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP307143.RAiUPzRdFA7nbE7t2c95cz4XfZwUe3BpnL5L1rWfUUvLk130_provenance.
• NP373123.RA2KTmOyHVinV-WZaOQdTABm1etdUSoz28hkBGzoxhBMQ130_assertion description "[In addition to previously described erbB2-regulating breast cancer Ets factors (PEA3, ESX/Elf-3), Elf-1 is now shown to be another endogenously expressed Ets candidate capable of binding to and upregulating the erbB2 promoter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP373123.RA2KTmOyHVinV-WZaOQdTABm1etdUSoz28hkBGzoxhBMQ130_provenance.
• NP307145.RANhbfsGrbJdi6IxhnqR23bMwG-VrJLCmDWv1eOr_5LRI130_assertion description "[In addition to previously described erbB2-regulating breast cancer Ets factors (PEA3, ESX/Elf-3), Elf-1 is now shown to be another endogenously expressed Ets candidate capable of binding to and upregulating the erbB2 promoter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP307145.RANhbfsGrbJdi6IxhnqR23bMwG-VrJLCmDWv1eOr_5LRI130_provenance.
• NP307140.RA_OkFuuo3Dc-X5EDhwIH3CmmS0GUnyLz28lw5lB-ABNA130_assertion description "[In addition to previously described erbB2-regulating breast cancer Ets factors (PEA3, ESX/Elf-3), Elf-1 is now shown to be another endogenously expressed Ets candidate capable of binding to and upregulating the erbB2 promoter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP307140.RA_OkFuuo3Dc-X5EDhwIH3CmmS0GUnyLz28lw5lB-ABNA130_provenance.
• NP307141.RA-zVIHTUFMZtlGHvaDzVKt_4YRCdtJQInCGKxi0LSLpw130_assertion description "[In addition to previously described erbB2-regulating breast cancer Ets factors (PEA3, ESX/Elf-3), Elf-1 is now shown to be another endogenously expressed Ets candidate capable of binding to and upregulating the erbB2 promoter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP307141.RA-zVIHTUFMZtlGHvaDzVKt_4YRCdtJQInCGKxi0LSLpw130_provenance.
• NP307144.RA3dCqo7Bm2N5m9R-wskOX8Vbm93puWRBt-apzKZu2d0o130_assertion description "[In addition to previously described erbB2-regulating breast cancer Ets factors (PEA3, ESX/Elf-3), Elf-1 is now shown to be another endogenously expressed Ets candidate capable of binding to and upregulating the erbB2 promoter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP307144.RA3dCqo7Bm2N5m9R-wskOX8Vbm93puWRBt-apzKZu2d0o130_provenance.